We are studying a new combination treatment for adults with relapsed or refractory FLT3-mutated acute myeloid leukemia. The goal is to see if this approach improves remission rates and safety compared to current options.
Health conditions and diseases that the clinical trial is designed to study and treat.
Acute Myeloid Leukaemia (AML) is a type of cancer that starts in the blood-forming cells of the bone marrow and progresses rapidly, leading to an increase in abnormal white blood cells. It can cause symptoms such as fatigue, fever, and easy bruising or bleeding.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.